Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with NPM1 Positive Acute Myeloid Leukemia

Documenti analoghi

• The number of additional high molecular risk mutations predicts outcome after hematopoietic stem cell transplantation in primary and secondary myelofibrosis
  di: Maria Chiara Finazzi, et al.
  Pubblicazione: (2025-10-01)
• High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)
  di: Salmoiraghi, Silvia, et al.
  Pubblicazione: (2020)
• Role of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Acute Lymphoblastic Leukemia
  di: Lussana, Federico, et al.
  Pubblicazione: (2014)
• MRD-Based Therapeutic Decisions in Genetically Defined Subsets of Adolescents and Young Adult Philadelphia-Negative ALL
  di: Tosi, Manuela, et al.
  Pubblicazione: (2021)
• Capture-Based Next-Generation Sequencing Improves the Identification of Immunoglobulin/T-Cell Receptor Clonal Markers and Gene Mutations in Adult Acute Lymphoblastic Leukemia Patients Lacking Molecular Probes
  di: Cavagna, Roberta, et al.
  Pubblicazione: (2020)